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Abstract 
Case report on B-cell acute lymphoblastic leukemia 
with t(2;9)(p11;p13) involving the immunoglobulin 
kappa locus (IGK) and PAX-5. 
Clinics 
Age and sex: 30 years old male patient. 
Previous history: no preleukemia, no previous 
malignancy, no inborn condition of note  
Organomegaly: no hepatomegal, no splenomegaly, 
enlarged lymph nodes (Tender right axillary, left 
posterior cervical, and left inguinal 
lymphadenopathy.), central nervous system 
involvement (Cytology revealed rare atypical 
mononuclear cells, favor reactive.) 
Blood 
WBC: 17.8X 109/l 
HB: 11.3g/dl 
Platelets: 38X 109/l 
Blasts: 85% 
Note Hypercellular marrow (>90%) with sheets of 
blasts on bone marrow core biopsy. Bone marrow 
aspirate smears contained 97% blasts with fine 
chromatin, single to multiple small nucleoli, and 
scant pale-blue cytoplasm. 
Cyto-Pathology 
Classification 
Immunophenotype Flow cytometric analysis of the 
peripheral blood identified a population of blasts 
(80% of all cells) expressing CD45, CD10, CD19, 
CD20, CD34, HLA-DR, CD33 (variable), CD11b 
(dim), cCD22, cCD79a, and nTdT. The blasts were 
negative for CD3, CD4, CD5, CD7, CD56, sIg 
kappa, sIg lambda, CD13, CD14, CD15, CD36, 
CD64, and cMPO. 
Rearranged Ig Tcr: Not performed 
Pathology: Acute lymphoblastic leukemia 
Electron microscopy: Not performed 
Diagnosis: B-lymphoblastic leukemia/lymphoma, 
not otherwise specified 
Survival 
Date of diagnosis: 04-2018 
Treatment: ECOG 1910 
Complete remission was obtained 
Treatment related death: no   
Relapse: No relapse in the context of a short follow-
up period 
Status: Alive 
Last follow up: 05-2018 
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Survival: 1months 
Karyotype 
Sample: Bone marrow 
Culture time: 24h 
Banding: GTG 
Results: 45,XY,t(2;9)(p11;p13),-20[18]/46,XY[1] 
Other Findings 
Genes involved and Proteins  
PAX5 (paired box gene 5) (9p13.2). The PAX5 
coding region extends over a genomic interval of 
approximately 200kb and comprises 10 exons. Two 
alternative transcripts have been identified, 
originating from alternative promotor usage, 
containing exon 1A or 1B. Full length mRNA is 
3650 bp. PAX5 belongs to the paired box family of 
transcription factors. It is involved in a multitude of 
developmental processes. PAX5 was originally 
identified as a B-cell specific transcription factor (B-
cell-specific activator protein, BSAP). Recently, 
PAX5 expression has been shown not only 
continuously required for B cell lineage commitment 
during early B cell development but also for B 
lineage maintenance. PAX5 contains a paired box 
(DNA binding) domain, a truncated homeo domain 
homology region, a transactivation domain, and an 
inhibitory domain.  
IGK (Immunoglobulin Kappa) (2p11.2). The human 
IGK locus at 2p12 spans 1820 kb. It consists of 76 
IGKV genes belonging to 7 subgroups, 5 IGKJ 
segments, and a unique IGKC gene. 
Comments 
Chromosomal translocations involving PAX5 are 
known to occur in cases of B-lymphoblastic 
leukemia (B-ALL), often involving a range of 
possible fusion gene partners (1). In addition to these 
rearrangements, many cases of B-ALL demonstrate 
copy number variations involving PAX5 (2).  
Despite these reports, only two other case of t(2;9) 
involving fusion of PAX5 and 2p11 have been 
reported to date (3,4).  
Neither of these reports confirmed the involvement 
of the immunoglobulin kappa locus as demonstrated 
in the present case. 
 We report the first case of PAX5/IgK fusion 
confirmed by FISH, suggesting a possible 
mechanism in B-ALL that mirrors other lymphomas 
which overexpress gene products as a result of 
joining with immunoglobulin heavy or light chain 
loci.  
Note from the Editor: this translocation is a variant 
of the rare t(9;14)(p13;q32) PAX5/IGH, although 
the t(9;14) has so far only been described in 
lymphomas. 
 
Example of chromosome 2;9 translocation. Note: A potential dicentric 9;20 was ruled out with centromeric probes of 
chromosome 9 and 20. FISH showing fusion (yellow) of IgK (green) [Cyto Cell] and PAX5 (red) [Empire Genomics] on the 
derived chromosome 9. Note: Negative for BCR/ABL1 fusion by FISH. 
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Two interphases demonstrating consistent connection of IgK (green)-PAX5 (red)-IgK (green) suggesting rearrangment/fusion of 
PAX5/IgK. 
 
Bone marrow core biopsy showing extensive blast proliferation and peripheral blood (inset) 
demonstrating atypical blast cytomtrating atypical blast cytomorphology with occasional deep nuclear fissures. 
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